High-purity peptide standards, custom synthetic sequences, and therapeutic active pharmaceutical ingredients for global research and industrial manufacturing.
An authoritative technical guide on custom ANP peptide synthesis, structural conformation challenges, purity analytics, and industrial supply chain integration for biopharmaceutical innovators.
Atrial Natriuretic Peptide (ANP), also designated as atrial natriuretic factor (ANF), is a 28-amino acid cyclic peptide hormone secreted primarily by cardiac atrium myocytes in response to high blood pressure and atrial distension. The primary human sequence (SLRRSSCFGGRMDRIGAQSGLGCNSFRY) contains a critical intramolecular disulfide bridge between Cys7 and Cys23, forming a 17-amino acid ring essential for high-affinity binding to Natriuretic Peptide Receptor-A (NPR-A / NPRA).
Synthesizing custom ANP peptides demands rigorous conformational control. The formation of the specific 17-member ring structure through selective oxidation of the cysteine residues is the primary determinant of biological potency, receptor affinity, and metabolic stability against neutral endopeptidase (NEP 24.11) degradation.
Industrial scale manufacturing of ANP derivatives (including linear precursors, scrambled controls, fluorophore-labeled analogues, and heavy isotope-labeled standards) presents complex chemical synthesis challenges:
Engineered chemical synthesis strategies optimizing peptide yield, folding accuracy, and batch-to-batch consistency.
We utilize high-efficiency Fmoc/tBu chemistry on low-loading CTC (Chlorotrityl chloride) or Rink Amide resins. Automated parallel synthesizers maintain precise temperature and microwave control, preventing racemization of sensitive Cys and Ser residues during coupling steps.
Forming the intramolecular disulfide bridge between Cys7 and Cys23 requires precise chemical discrimination. We deploy orthogonal protection techniques such as Cys(Trt) combined with dilute iodine solution oxidation, or Cys(Acm) protection for controlled liquid-phase cyclization, eliminating unwanted polymer formation.
Purification is performed on C18 reverse-phase silica columns using acetonitrile/water gradients containing trifluoroacetic acid (TFA). For downstream in vivo testing, custom salt exchange services (TFA conversion to Acetate or Hydrochloride salts) ensure low toxicity and maximal cellular biocompatibility.
| Grade Level | Purity Range | Analytical Package | Salt Form | Primary Application |
|---|---|---|---|---|
| Research Grade | ≥85% - ≥90% | HPLC, MS (ESI-MS / MALDI-TOF) | TFA Salt | In vitro screening, binding assays, ELISA standard development |
| Pre-Clinical Grade | ≥95% - ≥98% | HPLC, MS, Amino Acid Analysis (AAA), Endotoxin | Acetate / TFA | Animal model studies, metabolic stability assays, pharmacokinetics |
| cGMP API Grade | ≥98.5% - ≥99.0% | Full cGMP Validation, NMR, Residual Solvents, Heavy Metals | Acetate / Sterile Lyophilized | Human clinical trials, drug formulation, therapeutic injectable manufacture |
The global peptide therapeutics market is undergoing rapid expansion, projected to exceed USD 50 Billion in the coming decade. Driven by rising incidence of heart failure, chronic kidney disease (CKD), and refractory hypertension, research institutions and biopharmaceutical enterprises are intensifying drug discovery focused on the natriuretic peptide system.
Fast turnaround custom synthesis of modified ANP (e.g., N-terminal biotinylated, FITC-tagged, or stable isotope labeled) for ligand-receptor binding kinetics and cryo-EM structural biology studies.
Multi-gram to multi-kilogram non-cGMP and cGMP batch manufacturing supporting pharmaceutical companies through Investigational New Drug (IND) enabling studies and clinical trials.
Leveraging modern smart manufacturing, backward integration of raw materials, and robust quality control to deliver competitive global peptide sourcing solutions.
Our Hangzhou manufacturing center incorporates Industry 4.0 automated peptide synthesis arrays. Closed-loop sensor monitoring of solvent flow, coupling reaction temperatures, and real-time UV cleavage tracking reduces human error and maximizes batch reproducibility.
By producing standard Fmoc-protected amino acids, coupling reagents (HATU, HBTU, PyBOP), and specialty resin bases in-house, we insulate global clients from upstream supply chain disruptions while delivering significant cost savings.
Every custom ANP batch is accompanied by comprehensive analytical verification: High-Performance Liquid Chromatography (HPLC) chromatograms, Mass Spectrometry (MS) spectra, solubility certificates, and certificate of analysis (COA).
Answers to essential technical, logistical, and commercial inquiries regarding custom ANP peptide ordering.
Additional API products available for immediate order, contract development, and commercial supply chain integration.